Clinical trial
Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin
NCT03455985 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin
- Lead sponsor
- Ohio State University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 1, 2018
- Completion date
- September 11, 2020
- Enrollment
- 158 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood glucose, high, blood glucose, low, diabetes mellitus, type 2, patient discharge